A multicenter, open-label, exploratory platform study to evaluate biomarkers and immunotherapy combinations for the treatment of patients with metastatic castration-resistant prostate cancer (PORTER) Meeting Abstract
| Authors: | Nissola, L.; Autio, K.; Bhardwaj, N.; Galsky, M.; Wentzel, K.; Lucey, V.; Selinsky, C.; Perry, C.; Cabanski, C.; Bitton, A.; Fairchild, J.; Horak, C.; Skolnik, J.; Yellin, M.; Dugan, U.; Ibrahim, R.; Fong, L. |
| Abstract Title: | A multicenter, open-label, exploratory platform study to evaluate biomarkers and immunotherapy combinations for the treatment of patients with metastatic castration-resistant prostate cancer (PORTER) |
| Meeting Title: | 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) |
| Keywords: | placebo; ipilimumab; double-blind |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 7 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Nov 6-10 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2019-11-01 |
| Start Page: | 282 |
| Language: | English |
| ACCESSION: | WOS:000496473200807 |
| PROVIDER: | wos |
| PMCID: | PMC6833189 |
| PUBMED: | 31694725 |
| DOI: | 10.1186/s40425-019-0763-1 |
| Notes: | Meeting Abstract: P387 -- Source: Wos |
